While our data demonstrate a convincing reprogramming of NDFs, it is important to consider that CAFs derived from alternative cues, for example IL-1 or IL-6 signalling, will likely release sEVs with distinct cargo and therefore comparing sEVs from fibroblasts activated by different tumour signals warrants further investigation. The gene discussed is IL6; the disease is neoplasm.